Early graded exercise testing (GXT) after myocardial revascularization surgery (MRS) is safe. Testing timing and beta-blocker use did not significantly impact exercise response or safety in patients post-surgery.
Area of Science:
Cardiology
Exercise Physiology
Post-Surgical Rehabilitation
Background:
Myocardial revascularization surgery (MRS) necessitates careful post-operative management.
Early assessment of cardiac function through graded exercise testing (GXT) is crucial for recovery.
Understanding the impact of testing timing and medication on GXT outcomes is vital for patient care.
Purpose of the Study:
To evaluate the safety and efficacy of early graded exercise testing (GXT) in patients following myocardial revascularization surgery (MRS).
To determine the relationship between the timing of GXT post-MRS and patient outcomes.
To assess the influence of beta-blocker medication on GXT results in this patient population.
Main Methods:
227 patients underwent GXT at a mean of 15.3 days post-MRS using a modified Bruce protocol.
Patients were grouped by GXT timing: 7-14 days, 15-28 days, and >28 days.
Ventricular ectopic activity (VEA), ST-segment changes (STTC), heart rate (HR), blood pressure (BP), rate-pressure product (RPP), and metabolic equivalents (METs) were monitored. Beta-blocker use was recorded.
Main Results:
No major complications occurred during GXT.
Testing was mostly voluntarily terminated by patients (67.4%).
No association was found between GXT timing and STTC or VEA. Patients not on beta-blockers achieved higher peak HR, SBP, and RPP, but peak METs were unaffected by group or beta-blocker use.
Conclusions:
Early GXT (within 7-28 days) following MRS is safe and feasible.
While beta-blockers may influence hemodynamic responses, they do not appear to contraindicate early GXT.
GXT provides valuable data on exercise capacity and cardiac response in the early post-MRS period.